{"transactions":[{"id":2599964,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":136214,"kind":"person","name":"JENSEN GREG","position":1,"cik":"0001199647","reported_name":"JENSEN GREG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-17T20:20:07.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":192308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":192308,"derivative":{"exercise_price":1.27,"expiration_date":"2031-08-15","underlying":"Common Stock","underlying_shares":192308},"source":{"system":"sec-edgar","filing":"0001235802-21-000102","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580221000102/primary_doc.xml","form_type":"4"}},{"id":2599963,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":136214,"kind":"person","name":"JENSEN GREG","position":1,"cik":"0001199647","reported_name":"JENSEN GREG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance & CFO"}}],"security":"Common Stock, $0.000001 par value","published_at":"2021-08-17T20:20:07.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":285331,"source":{"system":"sec-edgar","filing":"0001235802-21-000102","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580221000102/primary_doc.xml","form_type":"4"}},{"id":3054157,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":136214,"kind":"person","name":"JENSEN GREG","position":1,"cik":"0001199647","reported_name":"JENSEN GREG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-19T00:24:13.000Z","date":"2020-08-15","kind":"grant","acquired":true,"shares":119942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 29,986 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments., subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":119942,"derivative":{"exercise_price":1.13,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":119942},"source":{"system":"sec-edgar","filing":"0001235802-20-000098","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580220000098/primary_doc.xml","form_type":"4"}},{"id":3054156,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":136214,"kind":"person","name":"JENSEN GREG","position":1,"cik":"0001199647","reported_name":"JENSEN GREG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and CFO"}}],"security":"Common Stock, $0.000001 par value","published_at":"2020-08-19T00:24:13.000Z","date":"2020-08-15","kind":"grant","acquired":true,"shares":95183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 23,796 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023 and with respect to 23,795 shares on August 15, 2024 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,607 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":129081,"source":{"system":"sec-edgar","filing":"0001235802-20-000098","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580220000098/primary_doc.xml","form_type":"4"}},{"id":3436053,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":136214,"kind":"person","name":"JENSEN GREG","position":1,"cik":"0001199647","reported_name":"JENSEN GREG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-16T20:09:46.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":39063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests with respect to 9,765 shares on August 15, 2020 and with respect to 9,766 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":39063,"derivative":{"exercise_price":2.76,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":39063},"source":{"system":"sec-edgar","filing":"0001235802-19-000103","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580219000103/primary_doc.xml","form_type":"4"}},{"id":3436052,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":136214,"kind":"person","name":"JENSEN GREG","position":1,"cik":"0001199647","reported_name":"JENSEN GREG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & CFO"}}],"security":"Common Stock, $0.000001 par value","published_at":"2019-08-16T20:09:46.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":33898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 8,474 shares on each of August 15, 2020 and August 15, 2021 and with respect to 8,475 shares on each of August 15, 2022 and August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares will vest and be issued with respect to 8,474 shares on each of August 15, 2020 and August 15, 2021 and with respect to 8,475 shares on each of August 15, 2022 and August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":33898,"source":{"system":"sec-edgar","filing":"0001235802-19-000103","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580219000103/primary_doc.xml","form_type":"4"}}]}